Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of microalbuminuria in obese children and its relation to metabolic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Several epidemiologic studies have clearly demonstrated that obesity increases the risk of kidney diseases. We have attempted to evaluate the association of obesity with albuminuria, an early marker of kidney disease, among obese children and its relation to metabolic syndrome. This study included 150 obese children. Blood pressure, fasting blood glucose, plasma insulin and the lipid profile were assessed. The homeostasis model assessment of insulin resistance (HOMA-IR) was used to calculate in vivo insulin resistance. Urinary albumin and creatinine were estimated. Microalbuminuria was detected in 22 (14.7%) of the obese children. Waist circumference, blood pressure, triglyceride, low-density lipoprotein (LDL), insulin resistance and fasting blood glucose were significantly higher in obese children with microalbuminuria than in those with normoalbuminuria and showed significant positive correlations with microalbuminuria. High-density lipoprotein (HDL) was significantly lower in obese children with microalbuminuria than in those with normoalbuminuria, with a significant negative correlation with microalbuminuria. We found that body mass index, abdominal obesity, hypertension, impaired fasting glucose level and insulin resistance significantly increased the odds of microalbuminuria in the obese children enrolled in this study. Moreover, high triglyceride, high LDL and low HDL were significantly associated with microalbuminuria. In our patient group, childhood obesity was a risk factor for the development of microalbuminuria, which in turn was significantly associated with metabolic syndrome and its different constituents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295(13):1549–1555

    Article  CAS  Google Scholar 

  2. Wang Y, Chen X, Klag MJ, Caballero B (2006) Epidemic of childhood obesity: implications for kidney disease. Adv Chronic Kidney Dis 13(4):336–351

    Article  Google Scholar 

  3. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ (2008) Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73(1):19–33

    Article  CAS  Google Scholar 

  4. Wahba IM, Mak RH (2007) Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2(3):550–562

    Article  CAS  Google Scholar 

  5. Sarafidis PA, Ruilope LM (2006) Insulin resistance, hyperinsulinemia and renal injury: mechanisms and implications. Am J Nephrol 26(3):232–244

    Article  Google Scholar 

  6. Savino A, Pelliccia P, Chiarelli F, Mohn A (2010) Obesity-related renal injury in childhood. Horm Res Paediatr 73(5):303–311

    Article  CAS  Google Scholar 

  7. Weisinger JR, Kempson RL, Elridge L, Swenson RS (1974) The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 81(4):440–447

    Article  CAS  Google Scholar 

  8. Cohen AH (1975) Massive obesity and the kidney. A morphologic and statistical study. Am J Pathol 81(1):117–130

    CAS  PubMed  PubMed Central  Google Scholar 

  9. de Jong PE, Curhan GC (2006) Screening, monitoring, and treatment of albuminuria. Public health perspectives. J Am Soc Nephrol 17(8):2120–2126

    Article  Google Scholar 

  10. Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, de Jong PE (2004) An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int Suppl 92:S18–S21

    Article  CAS  Google Scholar 

  11. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. National Center for Health Statistics, Hyattsville

    Google Scholar 

  12. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ, National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110(2):227–39

    Article  Google Scholar 

  13. Fernandez JR, Redden DT, Pietrobelli A, Allison DB (2004) Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 145(4):439–444

    Article  Google Scholar 

  14. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 114[Suppl 4th Report]:555–576

    Article  Google Scholar 

  15. American Academy of Pediatrics (1992) National cholesterol education program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89(3Pt 2):525–84

    Google Scholar 

  16. American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27[Suppl 1]:S5–S10

    Google Scholar 

  17. Basi S, Lewis JB (2006) Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis 47(6):927–946

    Article  CAS  Google Scholar 

  18. Nguyen S, McCulloch C, Brakeman P, Portale A, Hsu CY (2008) Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics 121(1):37–45

    Article  Google Scholar 

  19. Srivastava T (2006) Non diabetic consequences of obesity on kidney. Pediatr Nephrol 21(4):463–470

    Article  Google Scholar 

  20. Nenov VD, Taal MW, Sakharova OV, Brenner BM (2000) Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens 9(2):85–97

    Article  CAS  Google Scholar 

  21. Pinto-Sietsma SJ, Navis G, Janssen WMT, de Zeeuw D, Gans ROB, de Jong PE, for the PREVEND Study Group (2003) A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41(4):733–741

    Article  Google Scholar 

  22. Eppens MC, Craig ME, Cusumano J, Hing S, Chan AK, Howard NJ, Silink M, Donaghue KC (2006) Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29(6):1300–1306

    Article  Google Scholar 

  23. Caballero AE (2003) Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 11(11):1278–1289

    Article  CAS  Google Scholar 

  24. Ritz E (2003) Albuminuria and vascular damage: the vicious twins. N Engl J Med 348(23):2349–2352

    Article  Google Scholar 

  25. El-Atat FA, Stas SN, McFarlane SI, Sowers JR (2004) The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 15(11):2816–2827

    Article  Google Scholar 

  26. Kreisberg JI (1982) Insulin requirement for contraction of cultured rat glomerular mesangial cells in response to angiotensin. II: possible role for insulin in modulating glomerular hemodynamics. Proc Nat Acad Sci USA 79(13):4190–4192

    Article  CAS  Google Scholar 

  27. Ruster C, Wolf G (2006) Renin–angiotensin–aldosterone system and progression of renal disease. J Am Soc Nephrol 17(11):2985–2991

    Article  Google Scholar 

  28. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116(7):1784–92

    Article  CAS  Google Scholar 

  29. Margoni A, Perrea DN, Vlachos I, Prokopaki G, Pantopoulou A, Fotis L, KostakiM PAG (2011) Serum leptin, adiponectin and tumor necrosis factor in hyperlipidemic rats with/without concomitant diabetes mellitus. Mol Med 17(1–2):36–40

    Article  CAS  Google Scholar 

  30. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118(5):1645–1656

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Joachim H, Sharma K (2010) Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol 21(3):406–412

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatrics, Zagazig University, Zagazig City, El Sharkia Governorate, Egypt

    Mohammed Sanad

  2. Biochemistry, Zagazig University, Zagazig City, El Sharkia Governorate, Egypt

    Amal Gharib

Authors
  1. Mohammed Sanad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amal Gharib
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammed Sanad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanad, M., Gharib, A. Evaluation of microalbuminuria in obese children and its relation to metabolic syndrome. Pediatr Nephrol 26, 2193–2199 (2011). https://doi.org/10.1007/s00467-011-1931-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-011-1931-9

Keywords

Search

Navigation